1. Loona DPS, Das B, Kaur R, Kumar R, Yadav AK. Free Fatty Acid Receptors (FFARs): Emerging Therapeutic Targets for the Management of Diabetes Mellitus. Curr Med Chem 2023; 1(1): 1-10.
2. Yang Y, Wang Q, Li G, Guo W, Yang Z, Liu H, et al. Cysteine-Derived Chiral Carbon Quantum Dots: A Fibrinolytic Activity Regulator for Plasmin to Target the Human Islet Amyloid Polypeptide for Type 2 Diabetes Mellitus. Applied Materials & Interfaces 2023; 1(1): 1-10.
3. [3] Li H, Lu W, Wang A, Jiang H, Lyu J. Changing epidemiology of chronic kidney disease as a result of type 2 diabetes mellitus from 1990 to 2017: Estimates from Global Burden of Disease 2017. Journal of Diabetes Investigation 2021; 12(3): 346-56.
4. Paul RK, Ahmad I, Patel H, Kumar V, Raza K. Phytochemicals from Amberboa ramosa as potential DPP-IV inhibitors for the management of Type-II Diabetes Mellitus: Inferences from In-silico Investigations. Journal of Molecular Structure 2023; 1(1): 1-10.
5. Kim D, Alshuwaykh O, Dennis BB, Cholankeril G, Knowles JW, Ahmed A. Chronic liver disease-related mortality in diabetes before and during the COVID-19 in the United States. Dig Liver Dis 2023; 55(1): 3-10.
6. Khunti K, Valabhji J, Misra S. Diabetes and the COVID-19 pandemic. Diabetologia 2023; 66(2): 255-66.
7. Roncon L, Zuin M, Rigatelli G, Zuliani G. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome. J Clin Virol 2020; 127(1): 1-10.
8. Motakeffar M, Bakhshi Pour A, Ghasemi Motlagh M. Comparison of the effectiveness of mindfulness-based cognitive therapy and emotion-oriented therapy on self-care behaviors and sexual function in patients with type 2 diabetes. Journal of Sabzevar University of Medical Sciences 2022; 29(1): 131-41. [Farsi]
9. Puig-Domingo M, Marazuela M, Giustina A. COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology. Endocrine 2020; 68(1): 2-5.
10. Wang A, Zhao W, Xu Z, Gu J. Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed. Diabetes Res Clin Pract 2020; 162(1): 1-10.
11. Banerjee M, Chakraborty S, Pal R. Diabetes self-management amid COVID-19 pandemic. Diabetes Metab Syndr 2020; 14(4): 351-4.
12. Wicaksana AL, Hertanti NS, Ferdiana A, Pramono RB. Diabetes management and specific considerations for patients with diabetes during coronavirus diseases pandemic: A scoping review. Diabetes Metab Syndr 2020; 14(5): 1109-20.
13. Falcetta P, Aragona M, Ciccarone A, Bertolotto A, Campi F, Coppelli A, et al. Impact of COVID-19 lockdown on glucose control of elderly people with type 2 diabetes in Italy. Diabetes Res Clin Pract 2021; 174(1): 1-10.
14. Mottaghi S, Rahimian Boogar I, Moradi S, Sotodehasl N. Effectiveness of Face-to-Face and Online Methods of Cognitive-Behavioral Therapy Based on Stress Reduction on Diabetes Management Self-Efficacy and Adherence to Treatment among Patients with Diabetes during the Coronavirus Pandemic. J Diabetes Nurs 2022; 10(2): 1844-61. [Farsi]
15. Rahimian Boogar I, Mohajeri TMR, Besharat MA, Talepasand S. The effect of sociostructural and collaborative decision-making on diabetes self-management. Iranian J Publ Health 2013; 42(3): 280-92.
16. Van Cauwenberghe J, Enzlin P, Nefs G, Ruige J, Hendrieckx C, De Block C, et al. Prevalence of and risk factors for sexual dysfunctions in adults with type 1 or type 2 diabetes: results from Diabetes MILES‐Flanders. Diabetic Med 2022; 39(1): 1-10.
17. Masood SN, Saeed S, Lakho N, Masood Y, Rehman M, Memon S. Frequency of sexual dysfunction in women with diabetes mellitus: A cross-sectional multicenter study. Diabetol Pol 2021; 12(3): 357-62.
18. Winkley K, Kristensen C, Fosbury J. 2021. Sexual health and function in women with diabetes. Diabetic Med 2021; 38(11): 1-10.
19. Abedi AR, Aliakbari F, Mirzababaei M, Safian F, Shojaeefar E. Sexual Dysfunction in Iranian Men with Diabetes; a Systematic Review and Meta-analysis. Men's Health Journal 2021; 5(1): 10-21.
20. Liu S, Yang L, Zhang C, Xiang YT, Liu Z, Hu S, et al. Online mental health services in China during the COVID-19 outbreak. Lancet 2020; 7(4): 17-8.
21. Johansson M, Marcusson-Clavertz D, Gunnarsson C, Olsson I, Kaldo V, Bratt A. Feasibility and preliminary evaluation of internet-based compassion and cognitive–behavioral stress-management courses for health care professionals: A randomized controlled pilot trial. Internet Interventions 2022; 30(1): 1-10.
22. Carpenter KM, Stoner SA, Schmitz K, McGregor BA, Doorenbos AZ. An online stress management workbook for breast cancer. Chin J Behav Med 2014; 37(3): 458-68.
23. Markert C, Gomm C, Ehlert U, Gaab J, Nater UM. Effects of cognitive-behavioral stress management training in individuals with functional somatic symptoms–an exploratory randomized controlled trial. Stress 2019; 22(6): 696-706.
24. Wang AW, Bouchard LC, Gudenkauf LM, Jutagir DR, Fisher HM, Jacobs JM, et al. Differential psychological effects of cognitive-behavioral stress management among breast cancer patients with high and low initial cancer-specific distress. J Psychosom Res 2018; 113(1): 52-7.
25. Servant D, Rougegrez L, Barasino O, Demarty AL, Duhamel A, Vaiva G. Interest of computer-based cognitive behavioral stress management. Feasability of the Seren@ ctif program. L'encephale 2016; 42(5): 415-20.
26. Hall DL, Lattie EG, Milrad SF, Czaja S, Fletcher MA, Klimas N, et al. Telephone-administered versus live group cognitive behavioral stress management for adults with CFS. J psychosom Res 2017; 93(1): 41-7.
27. Heber E, Ebert DD, Lehr D, Cuijpers P, Berking M, Nobis S, et al. The benefit of web-and computer-based interventions for stress: a systematic review and meta-analysis. J Med Internet Res 2017; 19(2): 1-10.
28. Barroso J, Madisetti M, Mueller M. A feasibility study to develop and test a cognitive behavioral stress management mobile health application for HIV-related fatigue. J Pain Symptom Manage 2020; 59(2): 242-53.
29. Zhou X, Snoswell CL, Harding LE, Bambling M, Edirippulige S, Bai X, et al. The role of telehealth in reducing the mental health burden from COVID-19. Telemed e-Health 2020; 26(4): 377-9.
30. Rathbone AL, Clarry L, Prescott J. Assessing the efficacy of mobile health apps using the basic principles of cognitive behavioral therapy: systematic review. J Med Int Res 2017; 19(11): 1-10.
31. Gratzer D, Khalid-Khan F. Internet-delivered cognitive behavioural therapy in the treatment of psychiatric illness. CMAJ 2016; 188(4): 263-72.
32. Singh AK, Singh R. Does poor glucose control increase the severity and mortality in patients with diabetes and COVID-19? Diabetes Metab Syndr 2020; 14(5): 725-7.
33. Ghodrati Mirkouhi M, Rahimian Boogar I. Predicting diabetes management self-efficacy base on hardiness and coping strategies in patients with type 2 diabetes mellitus. J Inflam Dis 2016; 20(4): 43-51. [Farsi]
34. Bijl JVD, Poelgeest‐Eeltink AV, Shortridge‐Baggett L.The psychometric properties of the diabetes management self‐efficacy scale for patients with type 2 diabetes mellitus. J Advanc Nursing 1999; 30(2): 352-59.
35. Haghayegh A, Ghasemi N, Neshardoost HT, Kajbaf MB, Khanbani M. Psychometric Properties of Diabetes Management. Iranian Journal of Endocrinology and Metabolism 2010; 12(2): 111-5. [Farsi]
36. Sherer M, Maddux JE, Mercandante B, Prentice-Dunn S, Jacobs B, Rogers RW. The self-efficacy scale: Construction and validation. Psychological Reports 1982; 51(2): 663-71.
37. Boyer JG, Earp JAL. The development of an instrument for assessing the quality of life of people with diabetes: Diabetes-39. Med Care 1997; 1(2): 440-53.
38. Ware JJE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 1992; 1(1): 473-83.
39. Bazazian S, Rajab A. Assessing the psychometric properthes of the ouality of life scale for diabetics (developing over aged 20-60). J Develop Psycho 2010; 6(24): 317-28. [Farsi]
40. Besharat MA. Reliability and Validity of the Mental Health Inventory. Clinical Psychology and Personality 2006; 4(1): 11-6. [Farsi]
41. Antoni MH, Ironson G, Schneiderman N. Cognitive-behavioral stress management. Oxford University Press. 2007; 1-144.
42. Davazdah Emamy M, Roshan R, Mehrabi A, Attari A. The Effectiveness of Cognitive-Behavioral Stress Management Training on Glycemic Control and Depression in Patients with Type 2 Diabetes. IJEM 2009; 11(4): 385-92. [Farsi]
43. Mehrabi A, Fetty L, Davazdah Emamy M, Rajab A. The effectiveness of cognitive-behavioral stress management training on blood glucose control and reducing emotional problems in type 1 diabetic patients. Iranian Journal of Diabetes and Metabolism 2008; 8(2): 103-14. [Farsi]
44.